Pick-Two Consultancy provides a broad range of consulting services to the pharmaceutical and biotechnology industry, including:
Development and/or critical review of strategic chemistry and formulation (CM&C) plans for clinical supplies, registration or commercial production
What to do and what not to do (i.e., ways to save money without sacrificing quality)?
What to do first?
What to do in-house and what to contract out?
Identify gaps
Outsourcing strategy and tactics
Determining the “right” scope of work
Considering internal and external (e.g., FDA, licensing partners) customer needs
Preparing Request for Proposals (RFPs), while protecting your intellectual property and considering commercialization
Identify, pre-qualify, select and/or contract CROs and CMOs
Managing progress and/or resolving issues and problems to achieve your solution
Evaluation and/or development of supply chains
Pre- and post-commercialization supply chain planning
Determining the "right" supply chain for the near term and for the long run
Considering multiple factors; such as, risk tolerance, stage of life cycle, security of supply, degree of redundancy and quality assurance
Evaluate, on your behalf, the best price and the real price
Advise in launch preparation—timing, inventory build planning and system development (e.g., S&OP)
Solve organizational/operational issue and conduct due diligence
Practical approaches to solve organizational issues, spanning drug discovery, chemistry and formulation development and manufacturing, due to growth or resizing
Conduct due diligence, on your behalf, evaluating all aspects of chemistry and formulation R&D, and commercial product supply chains. Strong appreciation for intellectual property and its value to drug development and commercialization, along with diverse experience with a range of corporate cultures.
CMC contract review and/or negotiation
Evaluate and/or aid in your negotiation of supply, quality and/or R&D service agreements with careful consideration of inter-dependencies between agreements, and process improvement/cost reduction incentives.
Broad-based problem solving, based on experience spanning chemical/biochemical synthesis, analytical, physical properties, formulation and scale-up/validation
Assistance with risk management, based on good science and business considerations
Regulatory document review and evaluation
Assessing if there is too much or not enough detail